A dominant CD4(+) T-cell response to Helicobacter pylori reduces risk for gastric disease in humans.
暂无分享,去创建一个
Bin Li | Hong Guo | Jia-Lin He | Zhuo Zhao | Gang Guo | Jian Hu | Shu Yu | B. Li | Shiming Yang | Weisan Chen | Ming Zeng | Weisan Chen | Li Chen | Shi-Ming Yang | Bo-Sheng Li | D. Lu | Bosheng Li | X. Mao | G. Guo | Q. Zou | Xu-Hu Mao | Quan-Ming Zou | Hong Guo | Li Chen | Wu-Chen Yang | Ning-Yi Li | Ya-Fei He | Ping Luo | Jin-Yong Zhang | Hai-Bo Li | Dong-Shui Lu | Chao Wu | Haibo Li | Jinyong Zhang | P. Luo | M. Zeng | Shu Yu | Chao Wu | Zhuo Zhao | Wu-chen Yang | Jianjun He | Ning Li | Jian Hu | Yafei He | Bin Li
[1] A. D. De Groot,et al. An Integrated Genomic and Immunoinformatic Approach to H. pylori Vaccine Design. , 2011, Immunome research.
[2] K. Eaton,et al. The Role of T Cell Subsets and Cytokines in the Pathogenesis of Helicobacter pylori Gastritis in Mice1 , 2001, The Journal of Immunology.
[3] S. Lundin,et al. Increased frequency of activated T-cells in the Helicobacter pylori-infected antrum and duodenum. , 2003, FEMS immunology and medical microbiology.
[4] Jong-Bok Yoon,et al. Identification of immunodominant Helicobacter pylori proteins with reactivity to H. pylori-specific egg-yolk immunoglobulin. , 2003, Journal of medical microbiology.
[5] Benjamin L. King,et al. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori , 1999, Nature.
[6] M. de Carli,et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. , 1997, Journal of immunology.
[7] A. Svennerholm,et al. Flow cytometric analysis of the localization of Helicobacter pylori antigens during different growth phases. , 2001, FEMS immunology and medical microbiology.
[8] W. Kwok,et al. HLA Class II-Restricted CD4+ T Cell Responses Directed Against Influenza Viral Antigens Postinfluenza Vaccination 1 , 2003, The Journal of Immunology.
[9] R. Rappuoli,et al. Helicobacter pylori-specific CD4+ T-cell clones from peripheral blood and gastric biopsies , 1995, Infection and immunity.
[10] K. Hahm,et al. Association of the human leukocyte antigen class II alleles with chronic atrophic gastritis and gastric carcinoma in Koreans , 2009, Journal of digestive diseases.
[11] I. Kawamoto,et al. Against Helicobacter pylori composition containing 1-methylcarbapenem derivatives as active ingredient. , 1997 .
[12] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[13] P. O’Toole,et al. The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein , 1995, Journal of bacteriology.
[14] T. Sasazuki,et al. Contribution of major histocompatibility complex genes to susceptibility and resistance in Helicobacter pylori related diseases. , 1999, European journal of gastroenterology & hepatology.
[15] M. D’Elios,et al. Helicobacter pylori antigen-specific T-cell responses at gastric level in chronic gastritis, peptic ulcer, gastric cancer and low-grade mucosa-associated lymphoid tissue (MALT) lymphoma. , 2003, Microbes and infection.
[16] R. Rappuoli,et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[17] B. Hansen,et al. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules. , 2007, Tissue antigens.
[18] A. Svennerholm,et al. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses. , 2007, Vaccine.
[19] N. Mifsud,et al. Striking Immunodominance Hierarchy of Naturally Occurring CD8+ and CD4+ T Cell Responses to Tumor Antigen NY-ESO-11 , 2006, The Journal of Immunology.
[20] K. Blom,et al. HpaA shows variable surface localization but the gene expression is similar in different Helicobacter pylori strains. , 2001, Microbial pathogenesis.
[21] Y. Yamaoka,et al. Epidemiology of Helicobacter pylori Infection and Public Health Implications , 2011, Helicobacter.
[22] A. A. Akhiani,et al. Protection Against Helicobacter pylori Infection Following Immunization Is IL-12-Dependent and Mediated by Th1 Cells1 , 2002, The Journal of Immunology.
[23] M. D’Elios,et al. Different cytokine profile and antigen‐specificity repertoire in Helicobacter pylori‐specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer , 1997, European journal of immunology.
[24] W. Goebel,et al. Identification of Immunodominant Antigens fromHelicobacter pylori and Evaluation of Their Reactivities with Sera from Patients with Different Gastroduodenal Pathologies , 2000, Infection and Immunity.
[25] P. Doherty,et al. Systematic identification of immunodominant CD8+ T-cell responses to influenza A virus in HLA-A2 individuals , 2011, Proceedings of the National Academy of Sciences.
[26] E. Touati,et al. Pathogenesis of Helicobacter pylori Infection , 2009, Helicobacter.
[27] T. Ottenhoff,et al. Higher Frequency of T-Cell Response to M. tuberculosis Latency Antigen Rv2628 at the Site of Active Tuberculosis Disease than in Peripheral Blood , 2011, PloS one.
[28] Carl-Fredrik Flach,et al. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori. , 2011, Vaccine.
[29] S. Dandekar,et al. A predominant Th1 type of immune response is induced early during acute Helicobacter pylori infection in rhesus macaques. , 2000, Gastroenterology.
[30] D. Vergani,et al. Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross‐reactivity , 2004, Scandinavian journal of gastroenterology.
[31] C. Prinz,et al. Human Dendritic Cells Respond to Helicobacter pylori, Promoting NK Cell and Th1-Effector Responses In Vitro1 , 2004, The Journal of Immunology.
[32] E. Brooks,et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. , 1998, Gastroenterology.
[33] J. McCluskey,et al. Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] T. Monath,et al. Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Responses , 1998, The Journal of experimental medicine.
[35] Jie Yan,et al. Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients. , 2005, World journal of gastroenterology.
[36] C. Nilsson,et al. HpaA Is Essential for Helicobacter pylori Colonization in Mice , 2006, Infection and Immunity.